Service

Global Development

Unrivalled Global Study Services

  • We provide a stress free environment to conduct your trials

    Multilingual (Japanese/English/Korean/China, etc.)PMs with an extensive knowledge of regulatory and developmental trends in Asia are assigned to global studies.

  • Satisfaction Guaranteed with our Speed, Quality, and Cost

    Cross country and departmental cooperation keeps projects on track and delivers the highest levels of service across the board.

  • Serving the customer with the highest levels of efficacy

    Our proprietary overseas network and AI tools maximizes efficiency throughout development

“All Asia in Tokyo” We support Global Carries Out to and from Japan

Tokyo

Global PM・RA

Communication in Japanese &
Japan-Level quality

Clients

  • Pharmaceutical companies
  • Academia/ Researchers
  • Administration

Each Region

Development is led by Oncology and Regenerative Medicine specialists certified through our unique educational system.
We are able to provide a total solutions package to address project needs, and readily fulfill any requests at each phase of the study.

Message from Leader of Global Development

Global Newsletter Latest Articles

Global Newsletter

Volume of importing medical devices and updated medical device regulations in Thailand

According to the Plastic Institute of Thailand, Thailand's medical device imports grew by about 23% in the 2Q of 2021. And is expected to average 6.5% per year due to the aging of the population, rising demand for healthcare.

  • Thailand
  • Medical Equipment
  • Laws

Global Newsletter

Orphan Drugs and Rare Diseases in Asia.

Development of orphan drugs is often difficult to get off the ground due to the cost of manufacturing the drugs and the risk of sales. However, in Asia, many patients seeking treatment, even for very rare diseases.

  • Market
  • Laws
  • Approval

Global Newsletter

Differences in BE studies between Taiwan and Japan

Bioequivalence (BE) studies are performed to assess the in vivo biological equivalence between two pharmaceutical products. The regulations for BE studies in foreign countries can vary significantly in comparison to Japan.

  • Taiwan
  • Laws
  • Approval

Global Newsletter

Swift Market Authorization into Australia with COR-based Approach

In Australia, where the market for medical products is expanding, do you know that a regulatory scheme has been introduced to shorten the approval process for drugs that have already been submitted for marketing approval in other countries?

  • Australia
  • Laws
  • Approval
Read More